Medtronic (MDT) tops earnings estimates, raises guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Medtronic, Inc. (MDT) PT Raised to $95 at Stifel
August 22, 2023 3:58 PM EDTStifel analyst Rick Wise raised the price target on Medtronic, Inc. (NYSE: MDT) to $95.00 (from $92.00) while maintaining a Buy rating following earnings.
The analyst commented, "CEO Geoff Marthas transformation initiatives were more-visible than we expected, as evidenced by Medtronic's outperformance in what... More
